You searched for "regeneration"
Safety and efficacy of a nurse-led intravitreal injection service using an Precivia® injection assist device
Nurse-led intravitreal injections have become of great importance for busy eye units. In this article, the authors present safety data from five years of a nurse-led service with the use of the Precivia® intravitreal injection assist device. Intravitreal injections of...Patient and public participation shapes biomedical research and access priorities in eye health
Patients, clinicians and clinician-scientists play a valuable role in shaping the future of vision research. Limited funding demands targeted research initiatives that ultimately will shape health policy and practice to secure progress in improving patient outcomes in eye health. This...The fragile p-value
Abdus Samad Ansari explores the limitation of the p-value and the application of the fragility index in clinical trials. Clinical trials and tribulations? The restoration of vision or more purely the gift of sight is an aspect of care that...Real world data of post-IVT endophthalmitis, from a nurse-delivered intravitreal injection service
Introduction Intravitreal injection of neutralising anti-vascular endothelial growth factor (VEGF) antibody was licenced more than a decade ago, and over the years there has been proportionate increase in the number of intravitreal injections [1]. Injection of a therapeutic agent through...Running a high-volume nurse led intravitreal service using the Sp.eye device – the Stanley Eye Unit experience
Introduction The vast majority of ophthalmology units utilise allied healthcare professionals (AHPs) to deliver intravitreal injections (IVIs). The Royal College of Ophthalmologists issued a statement 10 years ago advocating the use of non-medical practitioners performing IVIs [1]. The main benefit...Ophthalmic surgeon returns to London Marathon after 31 years for Glaucoma UK
Michael Miller, in commemoration of Glaucoma UK's 50th anniversary, has achieved a remarkable feat by completing this year's London Marathon, three decades after he last completed the challenge in 1993, which he also ran in support of the charity.Breakthroughs in the genetics of angle-closure glaucoma
Angle closure glaucoma (ACG) is not widely known to be a familial condition, yet the recent explosion of genetic data and large scale genome wide investigations have confirmed at least 13 genetic loci associated with ACG [1], and provided some...AOP delivers world class education at record breaking 100% Optical
The AOP provided over 120 hours of CPD accredited sessions to thousands of delegates from 24 to 26 February.RCOphth 2024 Preview
Here is our annual highlights preview of the upcoming RCOphth 2024 Annual Congress in Belfast's ICC, 20-23 May.Brain tumours in adults: the essentials for an ophthalmologist
The author provides a review of the common intracranial tumours in adults (other than pituitaries) which may present to an ophthalmologist. Primary malignant brain tumours comprise 3% of adult cancers but with an ageing population such tumours are becoming more...Don’t ignore the black lesion! It might be mucormycosis
Keeping mucormycosis infection in the foreground of your differential diagnosis, especially in those more vulnerable patients, will help save their lives if recognised and managed appropriately. Mucormycosis is a fulminant infection caused by the fungi of the family Mucoraceae. It...
